As of 2015, Seles is a paid spokesperson for Shire Pharmaceuticals, the makers of the first drug approved by the Food and Drug Administration to treat BED, to raise awareness of the disorder she has suffered from since she was a young adult.
En 2015, Seles converteuse en voceira de Shire Pharmaceuticals, creadores do primeiro medicamento aprobado pola Food and Drug Administration para tratar o BED, para aumentar o coñecemento da desorde que ela mesma sufriu dende que era adolescente.